Results 261 to 270 of about 161,851 (302)
Some of the next articles are maybe not open access.
DSCG Reduces RSV‐induced illness in RSV‐infected mice
Journal of Medical Virology, 2008AbstractRespiratory syncytial virus (RSV) is one of the pathogens generally associated with the common cold, lower respiratory infection, and exacerbation of asthma. Disodium cromoglycate (DSCG) is a safe and widely used drug for the prevention of bronchial asthma and allergic rhinitis attacks.
Koichi, Hashimoto +10 more
openaire +2 more sources
Predicting the RSV Surge: Pediatric RSV Patterns of the COVID Pandemic
Pediatric Infectious Disease Journal, 2023Historically, respiratory syncytial virus (RSV) infection trends have been predictable. The COVID-19 pandemic and associated precautions impacted RSV disease patterns. RSV infection trends during the first year of the COVID-19 pandemic may have predicted the 2022 surge in pediatric RSV infections.
Sidney Zven +5 more
openaire +2 more sources
2021
Respiratory syncytial virus (RSV) causes severe respiratory tract infections in infants and elderly. Without antiviral therapies there is an urgent need for a RSV vaccine. Based on an exploratory study in non-human primates (NHP) and the importance of tissue-resident memory T cells for rapid mucosal immune responses the project aims to confirm the ...
openaire +1 more source
Respiratory syncytial virus (RSV) causes severe respiratory tract infections in infants and elderly. Without antiviral therapies there is an urgent need for a RSV vaccine. Based on an exploratory study in non-human primates (NHP) and the importance of tissue-resident memory T cells for rapid mucosal immune responses the project aims to confirm the ...
openaire +1 more source
Science immunology, 2020
A glycan-modified RSV nanoparticle vaccine displaying multimeric pre-F protein focuses antibody responses on neutralizing epitopes. Sharpening the focus of anti-RSV antibodies Respiratory syncytial virus (RSV) is a paramyxovirus that infects lung ...
K. Swanson +17 more
semanticscholar +1 more source
A glycan-modified RSV nanoparticle vaccine displaying multimeric pre-F protein focuses antibody responses on neutralizing epitopes. Sharpening the focus of anti-RSV antibodies Respiratory syncytial virus (RSV) is a paramyxovirus that infects lung ...
K. Swanson +17 more
semanticscholar +1 more source
Comparative study of RSV rescue from RSV‐transformed mammalian cells
International Journal of Cancer, 1971AbstractAll individual heterokaryons obtained by fusion of cells of the five different mammalian RSV‐transformed virogenic cells with indicator chicken fibroblasts produced infectious RSV. In contrast, non‐virogenic mammalian cells derived from tumours which arose in mice injected with RSV did not give rise to infectious RSV, even when fused with ...
J, Svoboda +3 more
openaire +2 more sources
Paediatric Respiratory Reviews, 2009
An economic analysis was performed in Spain to evaluate the efficiency (cost-effectiveness) of palivizumab in preventing severe RSV infection in premature infants with GA 32-35 and two or more risk factors (RF). The design was a decision tree model using data from the scientific literature and the FLIP I and FLIP II studies IRIS Study Group.
Xavier, Carbonell-Estrany +1 more
openaire +2 more sources
An economic analysis was performed in Spain to evaluate the efficiency (cost-effectiveness) of palivizumab in preventing severe RSV infection in premature infants with GA 32-35 and two or more risk factors (RF). The design was a decision tree model using data from the scientific literature and the FLIP I and FLIP II studies IRIS Study Group.
Xavier, Carbonell-Estrany +1 more
openaire +2 more sources